Clinical Values of Coagulation Factors X, XI, and XII in Cerebral Venous Sinus Thrombosis During Perinatal State
- PMID: 37697669
- PMCID: PMC10498691
- DOI: 10.1177/10760296231199732
Clinical Values of Coagulation Factors X, XI, and XII in Cerebral Venous Sinus Thrombosis During Perinatal State
Abstract
Cerebral venous sinus thrombosis (CVST) has become a rare but potentially life-threatening condition in perinatal women. Early and rapid identification of CVST in pregnant women is a challenge for frontline clinical workers. In this study, 40 perinatal patients with CVST in our hospital were included in the five-year period, and 120 normal perinatal pregnant women in the obstetrics and gynecology department of our hospital were randomly enrolled in the five-year period as the control group, including 60 cases in pregnancy and puerperium. 5 mL of fasting venous blood was collected from puerperal CVST patients in the acute phase of onset (within 72 h of onset) and the recovery phase (fourth week of treatment). In the control group, 5 mL of fasting venous blood was collected. Coagulation factors X, XI, and XII, plasma D-Dimer were analyzed and compared. Coagulation factors X, XI, and XII in plasma of CVST patients were significantly increased compared with controls. Plasma coagulation factors X, XI, and XII and their combined detection (Union Model = 0.056 * FX: C + 0.046 * FXI: C + 0.081 * FXII: C) have diagnostic values for perinatal CVST. Plasma coagulation factors X, XI, and XII were significantly positively correlated with plasma D-dimer levels in perinatal CVST patients. Plasma coagulation factors X, XI, and XII have diagnostic values for perinatal CVST.
Keywords: cerebral venous sinus thrombosis; coagulation factor; diagnosis; perinatal state.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures




Similar articles
-
Elevated factor XI is associated with increased risk of recurrent cerebral venous sinus thrombosis: a cohort study.J Thromb Thrombolysis. 2024 Mar;57(3):402-407. doi: 10.1007/s11239-023-02935-2. Epub 2023 Dec 25. J Thromb Thrombolysis. 2024. PMID: 38145433 Free PMC article.
-
Cerebral venous sinus thrombosis in pregnancy and puerperium.Acta Neurol Belg. 2021 Aug;121(4):967-972. doi: 10.1007/s13760-020-01459-3. Epub 2020 Aug 6. Acta Neurol Belg. 2021. PMID: 32761494
-
Evaluation of plasma D-dimer plus fibrinogen in predicting acute CVST.Int J Stroke. 2014 Feb;9(2):166-73. doi: 10.1111/ijs.12034. Epub 2013 Mar 19. Int J Stroke. 2014. PMID: 23506130 Free PMC article.
-
Complicated cerebral venous sinus thrombosis with intracranial hemorrhage and mastoiditis.Vasc Endovascular Surg. 2012 Oct;46(7):585-90. doi: 10.1177/1538574412457473. Epub 2012 Aug 22. Vasc Endovascular Surg. 2012. PMID: 22918938 Review.
-
Postpartum cerebral venous sinus thrombosis following obstetric neuraxial blockade: a literature review with analysis of 58 case reports.Int J Obstet Anesth. 2022 Feb;49:103218. doi: 10.1016/j.ijoa.2021.103218. Epub 2021 Sep 16. Int J Obstet Anesth. 2022. PMID: 34598860 Review.
References
-
- Ghoneim A, Straiton J, Pollard C, Macdonald K, Jampana R. Imaging of cerebral venous thrombosis. Clin Radiol. 2020;75(4):254‐264. - PubMed
-
- Rizk JG, Gupta A, Sardar P, et al. Clinical characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis: a review. JAMA Cardiol. 2021;6(12):1451‐1460. - PubMed
-
- Christensen R, Krishnan P, deVeber G, et al. Cerebral venous sinus thrombosis in preterm infants. Stroke. 2022;53(7):2241‐2248. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources